← Eichor
Study identifier: NCT06773364 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Early Initiated Ambulance-delivered Levetiracetam and Headposition in Hyper-acute Stroke Trial

Condition: Suspected Stroke  ·  Sponsor: Shanghai East Hospital

PhasePhase 3
Planned participants2423
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This is an investigator initiated and conducted, multicentre, ambulance-delivered, prospective, randomised, open-label, blinded outcome (PROBE) study. EAST aims to evaluate the effects of pre-hospital levetiracetam and different head positions initiated in ambulance settings on the functional outcome of participants assessed at 90 days.

This description comes directly from the study's public registry record.

Talk to the study team

Gang Li, PhD, MD  ·  86 13621691786  ·  ligang@tongji.edu.cn

Chen Chen, PhD, MD  ·  15921119641@163.com

Always discuss trial participation with your own doctor first.

Locations (2)

Si County People's HospitalSuzhou, Anhui, ChinaRecruiting
Shanghai East HospitalShanghai, Shanghai Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06773364